A. Lucas-Hahn
Friedrich Loeffler Institute
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by A. Lucas-Hahn.
Reproduction, Fertility and Development | 2017
S. M. Bernal-Ulloa; A. Lucas-Hahn; Patrick Aldag; Doris Herrmann; Ulrich Baulain; Klaus-Gerd Hadeler; Heiner Niemann
Oocyte culture in the presence of the nonspecific competitive phosphodiesterase inhibitor caffeine has been reported to increase developmental capacity of oocytes in different mammalian species. Here, we evaluated the effects of caffeine supplementation during the final phase of in vitro maturation (IVM) on developmental rates and blastocyst cell numbers. Bovine ovaries were collected from a local abattoir. A total of 1142 cumulus-oocyte-complexes were obtained by slicing. Cumulus-oocyte complexes were either in vitro matured for 24h (Standard) or matured for 20h followed by additional culture for 6h in fresh IVM medium supplemented with 10mM caffeine (Caffeine 6h). In vitro fertilization was performed for 19h using frozen-thawed sperm from 2 different bulls. After IVF, presumptive zygotes were cultured in vitro for 8 days until the blastocyst stage. Cleavage and blastocyst rates were evaluated 3 and 8 days after IVF, respectively. Expanded blastocysts from the different treatments were submitted to differential staining. SAS/STAT software (SAS Institute Inc., Cary, NC, USA) was used to evaluate cleavage and blastocyst rates using the Glimmix procedure and blastocyst cell numbers were compared using the linear model procedure. Cleavage rates were lower using caffeine for bull B and blastocyst production decreased for bull A. Caffeine treatment increased inner cell mass (ICM) number for bull B and decreased trophectoderm (TE) and total cell numbers for bull A. However, similar TE and total cells were obtained for bull B (Table 1; P<0.05). Results show that developmental competence can be affected by caffeine supplementation at the final phase of IVM probably due to oocyte-sperm interaction changes.
Reproduction, Fertility and Development | 2010
Ulrike Taylor; Wiebke Garrels; S. Petersen; Stephan Barcikowski; Sabine Klein; Wilfried August Kues; A. Lucas-Hahn; Heiner Niemann; Detlef Rath
Reproduction, Fertility and Development | 2008
Björn Petersen; A. Lucas-Hahn; Doris Herrmann; Wilfried August Kues; W. Ramackers; S. Bergmann; J.W. Carnwath; M. Winkler; Heiner Niemann
Theriogenology | 2016
Sandra Milena Bernal-Ulloa; A. Lucas-Hahn; Doris Herrmann; Klaus-Gerd Hadeler; Patrick Aldag; Ulrich Baulain; Heiner Niemann
Reproduction, Fertility and Development | 2006
Björn Petersen; Wilfried August Kues; A. Lucas-Hahn; Anna-Lisa Queisser; Erika Lemme; M. Hoelker; J.W. Carnwath; Heiner Niemann
Theriogenology | 1996
A. Lucas-Hahn; Judith Eckert; Heiner Niemann
Reproduction, Fertility and Development | 2015
S. M. Bernal; Julia Heinzmann; Doris Herrmann; Ulrich Baulain; Klaus-Gerd Hadeler; Patrick Aldag; A. Lucas-Hahn; Heiner Niemann
Reproduction, Fertility and Development | 2013
Ulrike Taylor; Wiebke Garrels; S. Petersen; Wilfried August Kues; A. Lucas-Hahn; Stephan Barcikowski; Detlef Rath
Xenotransplantation | 2011
Heiner Niemann; Björn Petersen; A. Lucas-Hahn; E. Lemme; M. Oropeza; D. Herrmann; Wilfried August Kues; B. Barg‐Kues; J. W. Carnwath
Reproduction, Fertility and Development | 2007
N. Hornen; Wilfried August Kues; A. Lucas-Hahn; Björn Petersen; Petra Hassel; Heiner Niemann